Anika Hansmann, Claudia Adolph, Tilmann Vogel, Andreas Unger and Gabriela Moeslein High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors Cancer 100
Article first published online: 19 DEC 2003 | DOI: 10.1002/cncr.11937
The current study describes the clinical course of 25 patients with familial adenomatous polyposis-associated and sporadic desmoid tumors who were treated with high-dose tamoxifen and sulindac.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field